recall
saveSomerset Therapeutics Private Limited recall (Cls II)
April 16, 2025updated 5mo ago
community read0 votes
Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 — Reason: Lack of Assurance of Sterility: Media fill with bacterial contamination — Status: Ongoing
view source ↗Data sources
last refreshed 39m ago
Found something off?
same company · ±60 days · 6
- recallSomerset Therapeutics Private Limited recall (Cls II)Apr 16, 2025
- recallSomerset Therapeutics Private Limited recall (Cls II)Apr 16, 2025
- recallSomerset Therapeutics Private Limited recall (Cls II)Apr 16, 2025
- recallSomerset Therapeutics Private Limited recall (Cls II)Apr 16, 2025
- recallAmerisource Health Services LLC recall (Cls II)Apr 30, 2025
- recallAmerisource Health Services LLC recall (Cls II)Apr 30, 2025
🐶 often sniffed alongside
top 8- tagRecall23 co-mentions · 13 sources
- drugHALOPERIDOL11 co-mentions · 7 sources
- drugHALOPERIDOL DECANOATE11 co-mentions · 7 sources
- drugdexamethasone SR6 co-mentions · 1 sources
- drugCISATRACURIUM BESYLATE6 co-mentions · 3 sources
- drugdexamethasone sodium phosphate SR4 co-mentions · 1 sources
- drugdexamethasone sodium phosphate4 co-mentions · 1 sources
- drugatropine2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that